Titan Biotech has informed that the trading window for dealing in the securities of the Company shall remain closed from Wednesday, October 01, 2025 till the expiry of 48 hours after the declaration of un-audited standalone & consolidated financial results of the company for the Quarter and half-year ending on September 30, 2025 for all Designated Persons, their Immediate Relatives and all Connected Persons covered under the Code. The date of the Board Meeting for consideration & approval of the un-audited standalone & consolidated financial results of the Company for the quarter and half-year ending on September 30, 2025, will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
